Baseline Interleukin-10, CD163 and Tumor Necrosis Factor-like Weak Inducer of Apoptosis Gingival Tissue Levels in Relation to Clinical Periodontal Treatment Outcomes : A 12-Week Follow-up Study

dc.contributor.authorYilmaz Mustafa
dc.contributor.authorDemir Esra
dc.contributor.authorGürsoy Mervi
dc.contributor.authorFiratli Erhan
dc.contributor.authorGürsoy Ulvi Kahraman
dc.contributor.organizationfi=hammaslääketieteen laitos|en=Institute of Dentistry|
dc.contributor.organization-code1.2.246.10.2458963.20.64787032594
dc.converis.publication-id175873885
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/175873885
dc.date.accessioned2022-10-28T12:22:27Z
dc.date.available2022-10-28T12:22:27Z
dc.description.abstract<p><strong>Background: </strong>The aim of this study was to examine the relationship between healing response after non-surgical periodontal treatment and baseline gingival tissue levels of M2 macrophage activation-related proteins CD163, interleukin (IL)-10, interferon (IFN)-γ, and tumor necrosis factor-like weak inducer of apoptosis (TWEAK), and the CD163/TWEAK ratio.</p><p><strong>Methods: </strong>Eighty-eight gingival tissue samples from 44 Stage III/IV, Grade C periodontitis patients (18 smokers) and 41 tissue samples from 41 periodontally healthy participants (18 smokers) were evaluated. Clinical parameters were recorded in periodontally healthy individuals at baseline and in periodontitis patients at pre-treatment and 2, 6, and 12 weeks following therapy. IL-10, IFN-γ, CD163, and TWEAK levels were analyzed with Luminex technique.</p><p><strong>Results: </strong>Tissue levels (median, 1<sup>st</sup> -3<sup>rd</sup> quartile) of IL-10 (pg/ng protein), CD163 (pg/μg protein) and TWEAK (pg/μg protein) were as follows: IL-10 periodontitis: 2.08, 0.86-5.32 and periodontally healthy: 5.22, 3.20-10.25; CD163 periodontitis: 8.85, 4.92-14.06 and periodontally healthy: 18.36, 12.51-34.02; TWEAK periodontitis: 0.08, 0.05-0.11 and periodontally healthy: 0.16, 0.12-0.21. IL-10, CD163, and TWEAK levels were higher (P < 0.001) in periodontally healthy tissues than in periodontitis tissues. Pocket closure at 12 weeks was associated with elevated baseline gingival CD163 levels (P = 0.047) and CD163/TWEAK ratio (P = 0.001). Elevated baseline gingival CD163/TWEAK ratio was associated with pocket reduction at 6 (P = 0.022) and 12 weeks (P = 0.002).</p><p><strong>Conclusion: </strong>Associations of pocket closure with pre-treatment gingival tissue CD163 levels and CD163/TWEAK ratio indicate that baseline M2 macrophage activation profile may play a role in periodontal wound healing.</p>
dc.identifier.jour-issn0022-3492
dc.identifier.olddbid176209
dc.identifier.oldhandle10024/159303
dc.identifier.urihttps://www.utupub.fi/handle/11111/31185
dc.identifier.urnURN:NBN:fi-fe2022091258540
dc.language.isoen
dc.okm.affiliatedauthorYilmaz, Mustafa
dc.okm.affiliatedauthorGursoy, Mervi
dc.okm.affiliatedauthorGursoy, Ulvi
dc.okm.discipline313 Dentistryen_GB
dc.okm.discipline313 Hammaslääketieteetfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.doi10.1002/JPER.22-0242
dc.relation.ispartofjournalJournal of Periodontology
dc.source.identifierhttps://www.utupub.fi/handle/10024/159303
dc.titleBaseline Interleukin-10, CD163 and Tumor Necrosis Factor-like Weak Inducer of Apoptosis Gingival Tissue Levels in Relation to Clinical Periodontal Treatment Outcomes : A 12-Week Follow-up Study
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Journal of Periodontology - 2022 - Yilmaz - Baseline interleukin‐10 CD163 and tumor necrosis factor‐like weak inducer of.pdf
Size:
438.29 KB
Format:
Adobe Portable Document Format